Answers are grounded in this paper and cite their sources.
The emergence of antimicrobial resistance and persistent bacterial biofilms has increased the need for effective and sustainable antimicrobial strategies. This study evaluated silver nanoparticles (BC-CFS-AgNPs) biosynthesized using cell-free supernatant (CFS) of Bacillus coagulans isolated from Indonesian traditional fermented fish paste (Terasi ikan). The synthesized AgNPs were characterized using UV–visible spectroscopy, FTIR, dynamic light scattering (DLS), zeta potential analysis, FE-TEM, SAED, elemental mapping, and EDX. The antimicrobial, antibiofilm, established-biofilm biomass reduction, and antivirulence activities of B. coagulans freeze-dried cell-free (BC-FD) and B. coagulans CFS-mediated AgNPs (BC-CFS-AgNPs) were evaluated against eight clinically relevant bacterial pathogens. Optical absorption was higher after 24 h than after 2 h. FE-TEM showed predominantly spherical and well-dispersed nanoparticles associated with a biological matrix, DLS gave a Z-average hydrodynamic diameter of 155.88 nm and the zeta potential was −25.24 mV, while FTIR suggested the involvement of biomolecules in nanoparticle formation and stabilization. CFS showed broad-spectrum antimicrobial and antibiofilm activity; conversion to BC-CFS-AgNPs lowered the minimum inhibitory concentration (MIC) values and the mass concentrations needed for biofilm inhibition, although the maximum percentage of biofilm inhibition was not consistently higher than that of CFS alone. BC-CFS-AgNPs also reduced pyoverdine and staphyloxanthin levels at lower concentrations than CFS alone. Colony-forming unit (CFU) counts of biofilm-associated cells showed a significant but pathogen-dependent loss of viability, and for several BC-CFS-AgNP treatments the fall in viable counts was much smaller than the fall in crystal violet biomass. These findings support B. coagulans CFS as a biological platform for green AgNP synthesis and justify further study of BC-CFS-AgNPs as a sustainable strategy for controlling biofilm-associated bacterial pathogens.
No takes yet. Share an insight, caveat, or question.
Setiaputri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: